Categories: aggregated

Buy! Sell! Puff, Puff, Pass! – Wall Street Drops Drug Testing for Cannabis, What It Could Mean for Your 401k

This trend among Wall Street institutions reflects a broader reevaluation of cannabis nationwide, influenced by its legal status in multiple U.S. states and evolving public sentiment. The shift is driven in part by practical considerations, such as the difficulty of enforcing stringent drug-free policies in areas where cannabis is legal and the necessity of attracting top talent in a competitive job market.

Jason

Share
Published by
Jason

Recent Posts

Did Tupac’s Friends Really Smoke His Ashes? The Full Story Behind the Legend

Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…

6 hours ago

Land of the Free? US Recorded More Than 200,000 Marijuana Possession Arrests in 2025

State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…

6 hours ago

Black Cannabis Week Returns to Philadelphia Sept. 25-27, With a Free Expungement Clinic

Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…

1 day ago

Barney’s Farm: 40 Years of Cannabis Seed Genetics

Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…

1 day ago

The Americans Most Convinced Weed Is Bad for You Don’t Smoke It Themselves. So, How Do They Know?

Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…

1 day ago

The FDA Wants to Know How You Use Cannabis—Useful or Concerning?

The FDA is seeking outside data and analytics services to better understand how people use…

1 day ago